SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-21-010437
Filing Date
2021-08-12
Accepted
2021-08-12 08:30:12
Documents
13
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K FINAL-sdgr-8k_20210812.htm   iXBRL 8-K 44593
2 EX-99.1 FINAL-sdgr-ex991_6.htm EX-99 570075
  Complete submission text file 0000950123-21-010437.txt   772112

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sdgr-20210812.xsd EX-101.SCH 5788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdgr-20210812_lab.xml EX-101.LAB 20227
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdgr-20210812_pre.xml EX-101.PRE 12093
6 EXTRACTED XBRL INSTANCE DOCUMENT FINAL-sdgr-8k_20210812_htm.xml XML 3679
Mailing Address 120 WEST 45TH STREET 17TH FLOOR NEW YORK NY 10036
Business Address 120 WEST 45TH STREET 17TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

IRS No.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39206 | Film No.: 211165595
SIC: 2834 Pharmaceutical Preparations